Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Oliveira

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Memorias Do Instituto Oswaldo Cruz|May 17, 2018
Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from BrazilLucia Elena Alvarado-Arnez, Angelica Martins Batista, Silvia Marinho Alves, et al.
Plos Neglected Tropical Diseases|May 22, 2024
The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruziGlaucia Vilar-Pereira, Daniel Gibaldi, Leda Castaño-Barrios, et al.
Parasitology International|May 19, 2018
Binding capacity of mannose-binding lectin (MBL) is associated with the severity of chronic Chagas cardiomyopathyElisa de A N Azevedo, Silvana Barreto, Raul Emídio de Lima, et al.
Tropical Medicine & International Health : TM & IH|May 28, 2025
Longitudinal monitoring of cell adhesion molecules in acute Chagas disease patients and prognosis after treatment with benznidazoleVictor Vaitkevicius-Antão, Bruno Almeida Silva, Michelle da Silva Barros, et al.
Plos Neglected Tropical Diseases|November 26, 2024
Influence of angiotensin II type 1 receptors and angiotensin-converting enzyme I/D gene polymorphisms on the progression of Chagas' heart disease in a Brazilian cohort: Impact of therapy on clinical outcomesThayse do Espírito Santo Protásio da Silva, Lucia Elena Alvarado-Arnez, Angelica Martins Batista, et al.
Frontiers in Immunology|March 24, 2025
Profile of soluble cell adhesion molecules as potential biomarkers in the cardiac stages of chronic Chagas diseaseVictor Vaitkevicius-Antão, Bruno Almeida Silva, Michelle da Silva Barros, et al.
Immunobiology|December 22, 2021
Is a negative correlation between sTNFR1 and TNF in patients with chronic Chagas disease the key to clinical progression?Diego José Lira Torres, Tiago Ribeiro De Arruda, Michelle da Silva Barros, et al.
Frontiers in Immunology|April 27, 2018
Genetic Polymorphism at <i>CCL5</i> Is Associated With Protection in Chagas' Heart Disease: Antagonistic Participation of CCR1<sup>+</sup> and CCR5<sup>+</sup> Cells in Chronic Chagasic CardiomyopathyAngelica Martins Batista, Lucia Elena Alvarado-Arnez, Silvia Marinho Alves, et al.
European Journal of Heart Failure|September 8, 2025
Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trialLuis Eduardo Echeverria, Edimar Bocchi, Caroline Demacq, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Memorias Do Instituto Oswaldo Cruz|May 17, 2018
Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from BrazilLucia Elena Alvarado-Arnez, Angelica Martins Batista, Silvia Marinho Alves, et al.
Plos Neglected Tropical Diseases|May 22, 2024
The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruziGlaucia Vilar-Pereira, Daniel Gibaldi, Leda Castaño-Barrios, et al.
Parasitology International|May 19, 2018
Binding capacity of mannose-binding lectin (MBL) is associated with the severity of chronic Chagas cardiomyopathyElisa de A N Azevedo, Silvana Barreto, Raul Emídio de Lima, et al.
Tropical Medicine & International Health : TM & IH|May 28, 2025
Longitudinal monitoring of cell adhesion molecules in acute Chagas disease patients and prognosis after treatment with benznidazoleVictor Vaitkevicius-Antão, Bruno Almeida Silva, Michelle da Silva Barros, et al.
Plos Neglected Tropical Diseases|November 26, 2024
Influence of angiotensin II type 1 receptors and angiotensin-converting enzyme I/D gene polymorphisms on the progression of Chagas' heart disease in a Brazilian cohort: Impact of therapy on clinical outcomesThayse do Espírito Santo Protásio da Silva, Lucia Elena Alvarado-Arnez, Angelica Martins Batista, et al.
Frontiers in Immunology|March 24, 2025
Profile of soluble cell adhesion molecules as potential biomarkers in the cardiac stages of chronic Chagas diseaseVictor Vaitkevicius-Antão, Bruno Almeida Silva, Michelle da Silva Barros, et al.
Immunobiology|December 22, 2021
Is a negative correlation between sTNFR1 and TNF in patients with chronic Chagas disease the key to clinical progression?Diego José Lira Torres, Tiago Ribeiro De Arruda, Michelle da Silva Barros, et al.
Frontiers in Immunology|April 27, 2018
Genetic Polymorphism at <i>CCL5</i> Is Associated With Protection in Chagas' Heart Disease: Antagonistic Participation of CCR1<sup>+</sup> and CCR5<sup>+</sup> Cells in Chronic Chagasic CardiomyopathyAngelica Martins Batista, Lucia Elena Alvarado-Arnez, Silvia Marinho Alves, et al.
European Journal of Heart Failure|September 8, 2025
Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trialLuis Eduardo Echeverria, Edimar Bocchi, Caroline Demacq, et al.
Pageof 2